Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512874 · ClinicalTrials.gov registry record · NA
Does Pulmonary Rehabilitation Improve Frailty?
A NA study of Disease, Pulmonary, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02512874: Completed NA study of Disease, Pulmonary, sponsored by Mayo Clinic.
NCT02512874 is a NA study of Disease, Pulmonary that has completed, run by Mayo Clinic. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02512874, a NA study of Disease, Pulmonary, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Frailty is a state of health with predisposition to adverse events, morbidity and mortality. Frailty consists of weakness, slowness, low physical activity, exhaustion, and wasting. Frailty is associated with increased hospitalizations and death in lung disease. It is unknown if pulmonary rehabilitation will improve frailty markers.
Primary Outcome
Frailty phenotype is 3 or more of: slow gait speed, exhaustion, decreased hand grip strength, decreased activity level, or wasting. Grip strength parameters, gait speed, exhaustion per Fried et al. 2001. Wasting is defined as further decrease in fat free mass by body composition measurement using DEXA. Low physical activity would be activity monitor in lower quartile.
Conditions Studied
Interventions
- DEVICE Activity Monitor
- DEVICE Dynamometer
- OTHER Pulmonary Rehabilitation
- RADIATION DEXA
- OTHER Gait Speed Test
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-07-21 |
| Est. Completion | 2018-10-16 |
| Phase | NA |
What the finished NCT02512874 record still lists
NCT02512874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Disease, Pulmonary appearing as the primary indexed condition, and to 5 interventions - of which Activity Monitor is the first listed.
NCT02512874 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02512874 about?
NCT02512874 is a clinical study titled "Does Pulmonary Rehabilitation Improve Frailty?". Frailty is a state of health with predisposition to adverse events, morbidity and mortality. Frailty consists of weakness, slowness, low physical activity, exhaustion, and wasting. Frailty is associated with increased hospitalizations and death in lung disease. It is unknown if pulmonary rehabilitat...
What is the current status of trial NCT02512874?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2015-07-21. Estimated completion is 2018-10-16.
What conditions does trial NCT02512874 study?
This clinical trial studies the following conditions: Disease, Pulmonary.
What interventions are being tested in trial NCT02512874?
The interventions under investigation include: Activity Monitor (DEVICE), Dynamometer (DEVICE), Pulmonary Rehabilitation (OTHER), DEXA (RADIATION), Gait Speed Test (OTHER).
Who is sponsoring clinical trial NCT02512874?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02512874 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02512874's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI